TerraMarine brings gout relief closer

Science Centres: Fisheries

TerraMarine Pharmaceuticals – a joint venture between NIWA, Crop & Food Research, and the Malaghan Institute of Medical Research – has filed a patent for a range of compounds designed primarily to relieve acute gout symptoms.

The group hopes to begin pre-clinical development in the near future, with the aim of conducting clinical trials in New Zealand. TerraMarine’s science programme, led by NIWA’s Dr Vicky Webb, was set up in 2002 to discover and commercialise new non-steroidal antiinflammatory drugs derived from New Zealand plants and marine organisms.